AMERSFOORT, Netherlands--(BUSINESS WIRE)--Medisse, a medical device company focused on the development of a new generation of resorbable flexible implants for soft tissue applications, announced today that its shareholders have appointed Alexander Vos to its Supervisory Board. Mr. Vos is currently CEO of Pharmacell, a company that provides contract services in the area of human cell and tissue culturing. Mr. Vos is a seasoned executive with more than 20 years of leadership experience in the pharmaceutical and biotech industries. He previously held senior management positions at Genzyme Europe, MediService (Switzerland) and PAION (Germany).
